NPHS1 and diabetic kidney disease: We also found the expression of nephrin decreased significantly in DKD models, and QRXZYQF treatment could increase the expression of nephrin, both in vivo and in vitro, suggesting that QRXZYQF had a certain protective effect on podocytes.